Cargando…

Thymoquinone Plus Immunotherapy in Extra-Pulmonary Neuroendocrine Carcinoma: Case Series for a Novel Combination

Background: Neuroendocrine neoplasms (NENs) are a heterogeneous group of cancers that had a significant increase in annual incidence in the last decade. They can be divided into well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs). Poorly differ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohamed, Amr, Azmi, Asfar S., Asa, Sylvia L., Tirumani, Sree Harsha, Mahipal, Amit, Cjakrabarti, Sakti, Bajor, David, Selfridge, J. Eva, Kaseb, Ahmed O.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9689659/ https://www.ncbi.nlm.nih.gov/pubmed/36421360 http://dx.doi.org/10.3390/curroncol29110707

Ejemplares similares

Management of Appendix Neuroendocrine Neoplasms: Insights on the Current Guidelines
por: Mohamed, Amr, et al.
Publicado: (2022)

The predictive impact of dual somatostatin receptor/fluorodeoxyglucose (FDG) positron emission tomography (PET) in metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs): review of literature and a single institution experience
por: Mohamed, Amr, et al.
Publicado: (2023)

Hypercalcemia of malignancy caused by parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumors (PTHrP-PNETs): Case Report
por: Pitts, Stephanie, et al.
Publicado: (2023)

A Patient With Locally Advanced Mismatch-Repair-Deficient Pancreatic Ductal Adenocarcinoma Successfully Treated With Neoadjuvant Immunotherapy
por: Cox, Ronald E, et al.
Publicado: (2021)

A glimpse into the future of esophageal carcinoma in the United States: predicting the future incidence until 2040 based on the current epidemiological data
por: Tella, Sri Harsha, et al.
Publicado: (2023)

The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs)
por: Mohamed, Amr, et al.
Publicado: (2022)

Exploring Real World Outcomes with Nivolumab Plus Ipilimumab in Patients with Metastatic Extra-Pulmonary Neuroendocrine Carcinoma (EP-NEC)
por: Mohamed, Amr, et al.
Publicado: (2022)

Update on Gastrointestinal Stromal Tumors for Radiologists
por: Tirumani, Sree Harsha, et al.
Publicado: (2017)

Current Concepts in Non-Gastrointestinal Stromal Tumor Soft Tissue Sarcomas: A Primer for Radiologists
por: Baheti, Akshay D., et al.
Publicado: (2017)

Efficacy of Immune Checkpoint Inhibitors against Advanced or Metastatic Neuroendocrine Neoplasms: A Systematic Review and Meta-Analysis
por: Park, Eun-Joo, et al.
Publicado: (2022)

Immunotherapy in Hepatocellular Carcinoma: Is There a Light at the End of the Tunnel?
por: Mahipal, Amit, et al.
Publicado: (2019)

Targeted Therapies in Advanced Biliary Tract Cancer: An Evolving Paradigm
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Systemic Therapy of Metastatic Pancreatic Adenocarcinoma: Current Status, Challenges, and Opportunities
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

Non-Invasive Diagnosis of Abdomino-Pelvic Masses: Role of Multimodality Imaging
por: Ojili, Vijayanadh, et al.
Publicado: (2013)

Immune-Checkpoint Inhibitors in the Era of Precision Medicine: What Radiologists Should Know
por: Braschi-Amirfarzan, Marta, et al.
Publicado: (2017)

Cancer genome landscape: a radiologist’s guide to cancer genome medicine with imaging correlates
por: Alessandrino, Francesco, et al.
Publicado: (2019)

Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations
por: Mpilla, Gabriel Benyomo, et al.
Publicado: (2020)

Metastatic pattern of uterine leiomyosarcoma: retrospective analysis of the predictors and outcome in 113 patients
por: Tirumani, Sree Harsha, et al.
Publicado: (2014)

The Promise of Circulating Tumor DNA (ctDNA) in the Management of Early-Stage Colon Cancer: A Critical Review
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Beyond PET/CT in Hodgkin lymphoma: a comprehensive review of the role of imaging at initial presentation, during follow-up and for assessment of treatment-related complications
por: Keraliya, Abhishek R., et al.
Publicado: (2015)

What Is New in the 2017 World Health Organization Classification and 8th American Joint Committee on Cancer Staging System for Pancreatic Neuroendocrine Neoplasms?
por: Choe, Jooae, et al.
Publicado: (2019)

Treatment Options for Pancreatic Neuroendocrine Tumors
por: Akirov, Amit, et al.
Publicado: (2019)

Immunotherapy in hepatocellular carcinoma: evaluation and management of adverse events associated with atezolizumab plus bevacizumab
por: Hsu, Chiun, et al.
Publicado: (2021)

Early stage colon cancer: Current treatment standards, evolving paradigms, and future directions
por: Chakrabarti, Sakti, et al.
Publicado: (2020)

Prostate Surface Distension and Tumor Texture Descriptors From Pre-Treatment MRI Are Associated With Biochemical Recurrence Following Radical Prostatectomy: Preliminary Findings
por: Shiradkar, Rakesh, et al.
Publicado: (2022)

Is thymoquinone an antioxidant?
por: Staniek, Katrin, et al.
Publicado: (2010)

Considerations in imaging interpretations for colitis in critically ill patients during the COVID-19 era
por: Martin, Sooyoung, et al.
Publicado: (2021)

Finding Waldo: The Evolving Paradigm of Circulating Tumor DNA (ctDNA)—Guided Minimal Residual Disease (MRD) Assessment in Colorectal Cancer (CRC)
por: Chakrabarti, Sakti, et al.
Publicado: (2022)

An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study
por: Hiremath, Amogh, et al.
Publicado: (2021)

MDCT of abdominopelvic oncologic emergencies
por: Tirumani, Sree Harsha, et al.
Publicado: (2013)

Systemic treatment in breast cancer: a primer for radiologists
por: Michaels, Aya Y., et al.
Publicado: (2015)

Modulation of Hydrogen Peroxide-Induced Oxidative Stress in Human Neuronal Cells by Thymoquinone-Rich Fraction and Thymoquinone via Transcriptomic Regulation of Antioxidant and Apoptotic Signaling Genes
por: Ismail, Norsharina, et al.
Publicado: (2016)

Thymoquinone’s Antiviral Effects: It is Time to be Proven in the Covid-19 Pandemic Era and its Omicron Variant Surge
por: Abdelrahim, Maen, et al.
Publicado: (2022)

An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence
por: Kalisz, Kevin, et al.
Publicado: (2019)

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma
por: Tella, Sri Harsha, et al.
Publicado: (2023)

Anticancer and Anti-Metastatic Role of Thymoquinone: Regulation of Oncogenic Signaling Cascades by Thymoquinone
por: Farooqi, Ammad Ahmad, et al.
Publicado: (2022)

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
por: Asa, Sylvia L., et al.
Publicado: (2021)

Mucinous neoplasms of the appendix: a current comprehensive clinicopathologic and imaging review
por: Tirumani, Sree Harsha, et al.
Publicado: (2013)

Malignant abdominal rocks: where do they come from?
por: Cheng, Joan M., et al.
Publicado: (2013)

Delta radiomic patterns on serial bi-parametric MRI are associated with pathologic upgrading in prostate cancer patients on active surveillance: preliminary findings
por: Midya, Abhishek, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r63a2lu9gred317j3b6cgtkq3g